The Role of TNF-α and its Receptors in the Production of β-1,4-galactosyltransferase I mRNA by Rat Primary Type-2 Astrocytes

Asano M, Nakae S et al (2003) Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4-galactosyltransferase-I-deficient mice Blood 102(5):1678–1685

Aschner M (1998) Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19(2):269–281

Aschner M, Sonnewald U et al (2002) Astrocyte modulation of neurotoxic injury. Brain Pathol 12(4):475–481

Collins T, Read MA et al (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9(10):899–909

Eisenbarth GS, Walsh FS et al (1979). Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A 76(10):4913–4917

Garcia-Vallejo JJ, van Dijk W et al (2005) Tumor necrosis factor-alpha up-regulates the expression of beta1,4-galactosyltransferase I in primary human endothelial cells by mRNA stabilization. J Biol Chem 280(13):12676–12682

Huang Q, Shur BD et al (1995) Overexpressing cell surface beta 1.4-galactosyltransferase in PC12 cells increases neurite outgrowth on laminin. J Cell Sci 108(Pt 2):839–847

Korner H, Riminton DS et al (1997) Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 186(9):1585–1590

Kuno R, Wang J et al (2005) Autocrine activation of microglia by tumor necrosis factor-alpha. J Neuroimmunol 162(1–2):89–96

Kuno R, Yoshida Y et al (2006) The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res 1116(1):12–18

Lu Q, Shur BD (1997) Sperm from beta 1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida poorly. Development 124(20):4121–4131

Lung HL, Leung KN et al (2001) Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-alpha in rat primary astrocytes. Life Sci 68(18):2081–2091

McFarlane SM, Pashmi G et al (2002) Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett 515(1–3):119–126

Quintana A, Giralt M et al (2005) Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res 82(5):701–716

Raff MC, Abney ER et al (1983) Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci 3(6):1289–1300

Raff MC, Abney ER et al (1984) Two glial cell lineages diverge prenatally in rat optic nerve. Dev Biol 106(1):53–60

Raff MC, Miller RH et al (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303(5916):390–396

Sawada M, Kondo N et al (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491(2):394–397

Shaper NL, Shaper JH et al (1986) Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A 83(6):1573–1577

Shi X, Amindari S et al (2001) Cell surface beta-1,4-galactosyltransferase-I activates G protein-dependent exocytotic signaling. Development 128(5):645–654

Shur BD (1991) Cell surface beta 1,4 galactosyltransferase: twenty years later. Glycobiology 1(6):563–575

Shur BD, Evans S et al (1998) Cell surface galactosyltransferase: current issues. Glycoconj J 15(6):537–548

Ulevitch RJ, Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437–457

Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3(2):97–130

Wang H, Czura CJ, Tracey KJ (2003). Tumor necrosis factor. In: Thomson AW, Lotze MT (eds) From the cytokine handbook, vol 2, 4th edn. Academic Press, Amsterdam, pp 837–860

Wood PL (1995) Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 17(4):242–248